Science News : ACC 2012 : Saturday

Updated:Mar 26,2012

ACC.12 Opening Session and Late-Breaking Clinical Trials - Session 300
8-10 a.m. CST

acc12_pslides_perin-5Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure: The FOCUS Randomized Trial 
Emerson C. Perin, MD, PhD, Cardiovascular Cell Therapy Research Network (CCTRN), Houston, Texas 
Presentation slides  |  Summary slide
acc12_pslides_morrow-2Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P): TIMI 50 Trial 
David A. Morrow, MD, Brigham & Women's Hospital, Boston, Mass.
Video interview  |  Presentation slides  |  Summary slide

FOCUS : ACC 2012


TIMI 50 Trial : Video Interview : ACC...


Related Statistics:
  • In 2009, the total number of inpatient cardiovascular operations and procedures increased 22%, from 6.1 million in 1999 to 7.5 million in 2009.
  • About 55% of procedures were performed on men, and 52% were performed on people 65 years of age and older.
  • The most common inpatient cardiovascular procedures in 2009 were angioplasty (1.13 million) and cardiac catheterization (1.07 million) accounting for about 30% of all cardiovascular procedures.

    Learn more in Heart Disease & Stroke Statistics: 2012 Update


Science News On-the-Go (ACC 2012)

Download the below MP3 files and listen to each interview on your mobile, in your own time.
Audio IconCPORT-E
Download MP3
Audio IconSafety and Efficacy of a Monoclonal Antibody...
Download MP3
MP3 (English)
  |  MP3 (French)
Audio IconISSUE-3
MP3 (English)  |  MP3 (Italian)
Download MP3
Audio IconFOCUS
Download MP3
Download MP3
Audio IconTIMI 50 Trial
Download MP3
Audio IconWelcome to ACC 2012 (Donna Arnett & Gordon Tomaselli)
Download MP3

ACC 2012: Welcome Video

Noticias Cientificas
Fall 2015

To submit feedback or to subscribe, follow @AHAScience (opens in new window) on Twitter and use #NoticiasCientíficas (opens in new window).